Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 26,735 | 39,516 | 26,501 | 13,571 | 59,998 |
| Depreciation Amortization | 117,178 | 68,368 | 44,933 | 22,106 | 82,386 |
| Income taxes - deferred | 4,967 | 458 | 429 | 325 | 2,170 |
| Accounts receivable | 4,733 | 2,692 | 2,096 | 6,219 | -6,397 |
| Other Working Capital | -4,779 | -186 | -3,829 | -2,171 | -559 |
| Other Operating Activity | -1,465 | -982 | -929 | -5,846 | 2,089 |
| Operating Cash Flow | $147,369 | $109,866 | $69,201 | $34,204 | $139,687 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -323,264 | -253,473 | -208,794 | -74,463 | -241,674 |
| Net Acquisitions | -4,100 | -4,100 | N/A | N/A | N/A |
| Other Investing Activity | 22,116 | 16,071 | 10,504 | 5,154 | 16,319 |
| Investing Cash Flow | $-305,248 | $-241,502 | $-198,290 | $-69,309 | $-225,355 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 748,731 | 450,731 | 236,831 | 94,581 | 372,510 |
| Debt Repayment | -581,739 | -301,234 | -104,714 | -59,952 | -245,136 |
| Common Stock Issued | 4,747 | 5,750 | 5,651 | 5,184 | 141 |
| Common Stock Repurchased | -12,997 | -12,158 | 0 | 0 | -31,395 |
| Other Financing Activity | -2,206 | -897 | -1,153 | -1,400 | -978 |
| Financing Cash Flow | $156,536 | $142,192 | $136,615 | $38,413 | $95,142 |
| Exchange Rate Effect | 75 | -209 | -217 | -469 | -1,394 |
| Beginning Cash Position | 53,821 | 53,821 | 53,821 | 53,821 | 45,741 |
| End Cash Position | 52,553 | 64,168 | 61,130 | 56,660 | 53,821 |
| Net Cash Flow | $-1,268 | $10,347 | $7,309 | $2,839 | $8,080 |
| Free Cash Flow | |||||
| Operating Cash Flow | 147,369 | 109,866 | 69,201 | 34,204 | 139,687 |
| Capital Expenditure | -389,414 | -304,661 | -236,927 | -88,347 | -307,311 |
| Free Cash Flow | -242,045 | -194,795 | -167,726 | -54,143 | -167,624 |